Transmedics Group Inc (TMDX) Growth Rates Comparisons to Medical Equipment & Supplies Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Transmedics Group Inc   (NASDAQ: TMDX)
 

Transmedics Group Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TMDX Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 41.15 % 8.19 % 10.18 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) 6.87 % -2.57 % -2.46 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 28.48 % 7.23 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 8.85 % 1.81 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 88.21 % 10.55 % 8.67 % 13.63 %


TMDX's Growth Comparisons in III. Quarter 2026




Transmedics Group Inc showed respectable 41.15% year on year rise of Revenue in the third quarter 2026, comparing favorably to the 8.19% growth in the Medical Equipment & Supplies industry, and 10.18% improvement in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Medical Equipment & Supplies industry, Transmedics Group Inc reported above average market Sales growth.

Comparing the company's Revenue to the second quarter results, sales were higher by 6.87% . On the yearly basis, average annual sales growth for Transmedics Group Inc is 88.21%, while S & P 500's including only Businesses with the third quarter 2026 earnings, average annual sales growth is 13.63% over the past five years.

TMDX Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product
-
51.76 %
Service
-
61.89 %
US
-
53.03 %
OCS transplant revenue
288.46 %
53.26 %
Heart Product
-
54.7 %
Liver revenue All Other Countries OCS transplant revenue
715.52 %
85.49 %
Service Unrelated to Transplant Procedures
-
-
Non Us
-
-
Total
41.15 %
6.87 %


Growth Rates of TMDX's Income in the third quarter 2026


TMDX Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 20.78 % 11.57 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) 18.56 % 101.75 % -12.21 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) -9.91 % 13.8 % 30.98 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) 5.93 % 3.53 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change - 11.5 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -29.8 % -73.24 % -38.86 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) 3.37 % 25.09 % -63.27 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 54.07 % 80.61 % 9.88 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) -4.88 % -1.66 % -4.67 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 5.35 % 8.91 % -28.64 %

TMDX Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -29.8 % -74.33 % -39.2 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) 3.37 % 44.21 % 11.78 % 27.07 %
Y / Y Net Income Change (Q3 TTM) 59.42 % -0.43 % 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) -4.72 % -3.35 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth - 4.12 % 9.09 % 23.95 %

TMDX's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -30.99 % -76.11 % -38.86 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) 16.67 % -63.27 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 55.72 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) -4.95 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -3.12 % 8.91 % -28.64 %



TMDX EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -30.3 % -77.09 % -39.2 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) 12.2 % 11.78 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) -5.17 % - 10.63 % 4.93 %
EPS Net 5 Year Avg. Change - 4.12 % 9.09 % 23.95 %



Transmedics Group Inc 's EPS went down by -30.3% from the same quarter a year ago, in the third quarter, to $ 0.46, and Medical Equipment & Supplies industry with -77.09%, and less than -39.2% slide in the Healthcare sector. Slow third quarter 2026 income per share in Medical Equipment & Supplies industry and Healthcare sector, were portrayed in Transmedics Group Inc 's results, which underperformed overall market.

The bottom-line improved by 12.2% from the second quarter. Looking into annual income per share rise of 88.21%, and S & P 500's average yearly income per share growth is 23.95% over the five years, including only Businesses with the third quarter 2026 earnings reports. Transmedics Group Inc grew faster than the market.

TMDX Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -55.44 % 47.51 % 44.26 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) 170.18 % -58.02 % -42.65 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) -62.95 % 44.19 % 19.33 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) -43.45 % 9.39 % 5.88 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 4.15 % 0.41 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) -90.08 % - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 102.2 % -9.69 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 10.18 % 4.57 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) 18.44 % -21.9 % -19.32 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) 18 % 1.49 % 9.34 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) 1.16 % -1.68 % 0.99 % 23.05 %
Capital Expenditures 5 Year Avg. Change 164.81 % 8.29 % 8.63 % 14.2 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.